HHS and FDA Announce Major Advances in Menopause Care with Updated Hormone Therapy Labeling

The U.S. Department of Health and Human Services (HHS), through the Food and Drug Administration (FDA), has approved updated labeling for three menopausal hormone therapy (MHT) products. This action aims to improve access and ensure adequate supply of these therapies, directly supporting efforts to advance women's health.